Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04170764 · ClinicalTrials.gov registry record
Clinical Utility of Postoperative Hemoglobin Testing
A clinical trial of Anaemia Postoperative, sponsored by TriHealth.
- Completed
- Registry status
- 664
- Enrollment target
- 1
- Study location
NCT04170764: Completed study of Anaemia Postoperative, sponsored by TriHealth.
NCT04170764 is a study of Anaemia Postoperative that has completed, run by TriHealth. The registered enrollment target is 664 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04170764, a study of Anaemia Postoperative, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 664 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate how many patients have hemoglobin less than 10 g/dL at post-operative day 1
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Urogynecology Associates - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 664 participants |
| Start Date | 2019-11-22 |
| Est. Completion | 2020-05-28 |
What the finished NCT04170764 record still lists
NCT04170764 is an observational study that tracks outcomes without assigning an intervention. The registered 664 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Anaemia Postoperative appearing as the primary indexed condition, and to 0 interventions.
NCT04170764 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04170764 about?
NCT04170764 is a clinical study titled "Clinical Utility of Postoperative Hemoglobin Testing". The purpose of this study is to evaluate how many patients have hemoglobin less than 10 g/dL at post-operative day 1
What is the current status of trial NCT04170764?
This trial is currently completed. The enrollment target is 664 participants. The study started on 2019-11-22. Estimated completion is 2020-05-28.
What conditions does trial NCT04170764 study?
This clinical trial studies the following conditions: Anaemia Postoperative.
Who is sponsoring clinical trial NCT04170764?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04170764 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06607341 · 664 participants · NA
Community Engagement Alliance Against Disparities
- NCT04064060 · 665 participants · Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- NCT07164443 · 663 participants · Phase 3
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NCT06328647 · 666 participants · NA
Quantra Point-of-Care Hemostasis Monitoring
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI